Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Illumina - Liquid biopsy-based biomarkers for cancer profiling and monitoring: current and future applications

Panel discuss

Date

15 Sep 2024

Session

Illumina - Liquid biopsy-based biomarkers for cancer profiling and monitoring: current and future applications

Topics

Cancer Diagnostics;  Cancer Research

Tumour Site

Presenters

Umberto Malapelle, Magdalena Meissner, Åslaug Helland, Stephen Rowley

Authors

U. Malapelle1, M. Meissner2, Å. Helland3, S.J. Rowley4

Author affiliations

  • 1 Public Health Dept., Università degli Studi di Napoli Federico II - Scuola di Medicina e Chirurgia, 80131 - Napoli/IT
  • 2 Early Phase Clinical Cancer Trials Dept., Velindre Cancer Centre - Velindre NHS University Trust - NHS Wales, CF14 2TL - Cardiff/GB
  • 3 Oslo University Hospital - The Norwegian Radium Hospital, 0379 - Oslo/NO
  • 4 Inspire2Live, 1069 LT - Amsterdam/NL

Resources

This content is available to ESMO members and event participants.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.